Rilzabrutinib
- Generic Name
- Rilzabrutinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C36H40FN9O3
- CAS Number
- 1575591-66-0
- Unique Ingredient Identifier
- 5G1WE425BI
- Background
Rilzabrutinib is an oral, reversible covalent inhibitor of Bruton's tyrosine kinase being investigated for the treatment of immune disorders, such as immune thrombocytopenic purpura.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath